JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
This is a global, open-label, randomized, 2-arm, Investigator\'s choice Phase 3 (Pivotal Stage) study to investigate the efficacy/performance and safety of NBTXR3/RT±cetuximab versus RT±cetuximab in treatment-naïve, platinum-ineligible, elderly participants with LA-HNSCC.
Epistemonikos ID: d25b8761435113bec0d3d8e46e44ab1e7d2015dd
First added on: May 08, 2024